PAVmed (PAVM) Operating Expenses (2015 - 2025)

PAVmed's Operating Expenses history runs 11 years deep, the most recent figure standing at $6.9 million for Q4 2025.

• On a quarterly basis, Operating Expenses rose 31.9% year-over-year to $6.9 million in Q4 2025; TTM through Dec 2025 was $21.9 million, a 37.32% decrease from a year earlier, with the FY2025 full-year figure at $21.9 million, down 53.93% from the prior year.
• Operating Expenses rose to $6.9 million in Q4 2025 per PAVM's latest filing, from $4.8 million in the prior quarter.
• Across five years, Operating Expenses topped out at $24.7 million in Q4 2022 and bottomed at $4.7 million in Q2 2025.
• The 5-year median for Operating Expenses is $15.0 million (2024), against an average of $14.4 million.
• Across the five-year window, Operating Expenses surged 164.41% in 2021 and tumbled 70.19% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $20.0 million in 2021, then increased by 23.69% to $24.7 million in 2022, then dropped by 29.46% to $17.4 million in 2023, then tumbled by 70.19% to $5.2 million in 2024, then jumped by 31.9% to $6.9 million in 2025.
• Per Business Quant, the three latest PAVM Operating Expenses figures stand at $6.9 million (Q4 2025), $4.8 million (Q3 2025), and $4.7 million (Q2 2025).